ct26 murine colorectal carcinoma cell line  (ATCC)

Journal: iScience

Article Title: Fluorescence tracking Treg movement identifies anti-CCR8 and radiation as a therapeutic combination

doi: 10.1016/j.isci.2025.114572

Figure Lengend Snippet: Combination RT and anti-CCR8 reduces tumor burden and improve survival in distant non-irradiated tumors BALB/c mice were injected with CT26 on both flanks. Tumor-bearing mice were treated with a “pre” treatment strategy. Mice were injected i.p. with anti-CCR8 on days 7, 10, and 14 and treated with 12 Gy RT to the right flank tumor (treated) on day14 post-tumor inoculation. The left tumor (untreated) did not receive RT. Tumor growth and survival were assessed. A total of 8 mice were analyzed per group. Data are represented as mean ± SD. Statistics for survival plots were performed using a Mantel-Cox test between groups. ns = not significant, ∗∗∗∗ p < 0.0001, ∗∗∗ p < 0.001, ∗∗ p < 0.01, ∗ p < 0.05.

Article Snippet: The CT26 murine colorectal carcinoma cell line was purchased from ATCC (CRL-2638).

Techniques: Irradiation, Injection

Journal: Cancers

Article Title: Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles

doi: 10.3390/cancers18010090

Figure Lengend Snippet: Intrinsic sensitivity of tumor cells to ECT in vitro. Intrinsic sensitivity of WEHI fibrosarcoma ( a ), CT26 colorectal carcinoma ( b ), 4T1 mammary carcinoma ( c ) and MC38 colorectal carcinoma ( d ) with corresponding IC50 values ( e ). * p < 0.05 indicates a significant difference compared to untreated control or EP group ( a – d ). ** p < 0.05 indicates a significant difference between indicated cell lines ( e ).

Article Snippet: Mammary carcinoma 4T1 cells, murine fibrosarcoma WEHI cells, and murine colorectal carcinoma CT26 cells (all from the American Type Culture Collection, Manassas, VA, USA) were cultured in Advanced RPMI-1640 medium (Gibco, Waltham, MA, USA).

Techniques: In Vitro, Control

Journal: Cancers

Article Title: Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles

doi: 10.3390/cancers18010090

Figure Lengend Snippet: Effectiveness of ECT in murine tumors. Growth curves of WEHI fibrosarcoma ( a ), CT26 colorectal carcinoma ( b ), 4T1 mammary carcinoma ( c ) and MC38 colorectal carcinoma ( d ) are presented as AM ± SE. cr = complete response, mice with cured tumors, number of animals = 12 in all other groups, then ECT. EP = electroporation, BLM = bleomycin, ECT = electrochemotherapy.

Article Snippet: Mammary carcinoma 4T1 cells, murine fibrosarcoma WEHI cells, and murine colorectal carcinoma CT26 cells (all from the American Type Culture Collection, Manassas, VA, USA) were cultured in Advanced RPMI-1640 medium (Gibco, Waltham, MA, USA).

Techniques: Electroporation

Journal: Cancers

Article Title: Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles

doi: 10.3390/cancers18010090

Figure Lengend Snippet: Effectiveness of anti-PD-1 immunotherapy in murine tumors. Growth curves of WEHI fibrosarcoma ( a ), CT26 colorectal carcinoma ( b ), 4T1 mammary carcinoma ( c ) and MC38 colorectal carcinoma ( d ) are presented as AM ± SE. number of animals = 12 in all groups.

Article Snippet: Mammary carcinoma 4T1 cells, murine fibrosarcoma WEHI cells, and murine colorectal carcinoma CT26 cells (all from the American Type Culture Collection, Manassas, VA, USA) were cultured in Advanced RPMI-1640 medium (Gibco, Waltham, MA, USA).

Techniques:

Journal: Cancers

Article Title: Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles

doi: 10.3390/cancers18010090

Figure Lengend Snippet: Effectiveness of combined ECT + anti-PD-1 treatment. Growth curves of CT26 colorectal carcinoma ( a ), 4T1 mammary carcinoma ( b ) and MC38 colorectal carcinoma ( c ) are presented as AM ± SE. CR = complete response, mice with cured tumors, number of animals = 15 in all other groups, then ECT + anti-PD-1. ECT = electrochemotherapy, BLM = bleomycin, ECT = electrochemotherapy.

Article Snippet: Mammary carcinoma 4T1 cells, murine fibrosarcoma WEHI cells, and murine colorectal carcinoma CT26 cells (all from the American Type Culture Collection, Manassas, VA, USA) were cultured in Advanced RPMI-1640 medium (Gibco, Waltham, MA, USA).

Techniques: